Health Condition 1: N189- Chronic kidney disease, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of age above 18 years, attending clinical pharmacology OPD. 2. Patient who was diagnosed with CKD (according to their eGFR and the presence of kidney injury as defined by the National Kidney Foundation K/DOQI Guideline).
Exclusion criteria
Exclusion criteria: 1. Patients who disagree to give consent, 2. patient on haemodialysis, 3. Patient with clinical history of active gastro-intestinal diseases, including gastroenteritis and peptic ulcers, liver cirrhosis, 4. Patient with a clinical history of atherosclerotic complications (coronary artery disease, congestive heart failure, or peripheral vascular disease), 5. Patient with acute kidney injury (KDIGO Clinical Practice Guideline for Acute Kidney Injury), 6. patient with a clinical history of malignancy including gastric cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It might be possible to detect CKD progression earlier in at-risk individuals attending clinical pharmacology OPD those who are receiving polypharmacy with the help of Trefoil factor 1Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| An association between polypharmacy and chronic kidney diseases might be establishedTimepoint: Baseline | — |
Countries
India
Contacts
R G Kar Medical College and Hospital